An interventional study of CBTi and Control - usual care in Diabetes Mellitus, Type 2, Insomnia and Sedentary Behavior, sponsored by University of Leicester. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2025-03-27.
Sponsored by University of Leicester · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 23 studies in Diabetes Mellitus, Type 2 by University of Leicester — 6 open to participants now, 6 under way, none of them phase 3. Diabetes Mellitus, Type 2 · University of Leicester.
Among the 23 studies in Diabetes Mellitus, Type 2 by University of Leicester, this one is the 6th largest by planned enrollment of the 12 interventional ones that give a count, is one of 3 that started in 2024, is one of 6 with no phase, and was the 22nd registered.
10,403 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,413 are open to participants now.
Browse Diabetes Mellitus, Type 2 studies →6 of the 23 studies in Diabetes Mellitus, Type 2 by University of Leicester are open now, in 1 country. Recruiting first, the newest first:
University of Leicester · Sites in United Kingdom
Ages 18+ · Healthy volunteers
University of Leicester · Sites in United Kingdom
Ages 18+ · Healthy volunteers
University of Leicester · Sites in United Kingdom
Ages 50–75 · Healthy volunteers
University of Leicester · Sites in United Kingdom
Ages 18–75
University of Leicester
Ages 18+
By country, each count listing its studies:
Of the 882 Diabetes Mellitus, Type 2 studies recruiting now, 372 (42%) set no upper age limit and 384 (44%) stop at 75 or younger; 52 take children under 18; 202 take healthy volunteers.
This study: 18 Years to 75 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
23 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 1 · Phase 3 2 · Phase 4 4
First in 2011; this study’s year is marked. 3 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 44 is below the median of 80 across 8,372 interventional studies indexed under Diabetes Mellitus, Type 2.
Median enrollment 44 across the 12 interventional studies, 241 across the 11 observational. Of the 16 that completed or were terminated, 1 (6%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of Leicester is the lead sponsor of 172 studies on the registry; 53 are open to participants now.
1 of the studies in Diabetes Mellitus, Type 2 by University of Leicester that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06652763University of LeicesterManganese-enhanced Magnetic Resonance Imaging (MEMRI) in Heart Failure With Preserved Ejection Fraction | 2026-11 |
Add it to your calendar (.ics) → With an account.
Among the 23 studies in Diabetes Mellitus, Type 2 by University of Leicester, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The goal of this clinical feasibility trial is to learn whether the investigators can improve sleep and reduce sedentary behaviour in people living with Type 2 diabetes mellitus with sleep problems. The main questions it aims to answer are: • question 1, can objectively measured sleep and sedentary behaviour be improved in the participants and • question 2, what effect will this have on a number of physical and physiological markers. Participants in the intervention group will be asked to keep sleep diaries and attend regular meetings with a qualified coach who will use a specific talking therapy to try to improve sleep and with use behaviour change techniques to help them be less sedentary. Researchers will compare the control group to the intervention group to see if effects differ between groups.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
HbA1c
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will be counselled in how to improve their sleep and decrease sedentary behaviour using CBTi and behaviour change techniques.
Behavioral: CBTi · Behavioral: Sedentary behaviour reduction
Participants will be given a leaflet containing brief information on good sleep hygiene practice and the benefits of decreasing sedentary behaviour.
Other: Control - usual care
A 12 week intervention using CBTi to improve sleep measured using objective and subjective measures. Participants will complete a number of questionnaires and tests at baseline and at completion to allow comparisons to be made.
Participants will be given a leaflet summarising good sleep practice and the advantages of reducing sedentary behaviour. Participants will complete a number of questionnaires and tests at baseline and at completion to allow comparisons to be made.
Participants will be encouraged to increase activity and thus reduce sedentary time. Investigators will use behaviour change techniques to aid in this goal. Participants will complete a number of questionnaires and tests at baseline and at completion to allow comparisons to be made.
Sleep Efficiency (SE) measured using accelerometer data.
The primary outcome measure is change in objectively measured SE in the intervention arm compared to the control group.
Time frame: Before and after the 12 week intervention/intervention period
Objectively measured sleep - sleep onset latency
Accelerometer data will be used to measure sleep onset latency in minutes.
Time frame: Before and after the 12 week intervention/intervention period
Objectively measured sleep - wake after sleep onset
Accelerometer data will be used to measure wake after sleep onset in minutes.
Time frame: Before and after the 12 week intervention/intervention period
Objectively measured sleep - total sleep time
Accelerometer data will be used to measure total sleep time in minutes.
Time frame: Before and after the 12 week intervention/intervention period
Objectively measured sleep - sleep duration variability
Accelerometer data will be used to measure sleep duration variability in minutes.
Time frame: Before and after the 12 week intervention/intervention period
Objectively measured sleep - sleep midpoint variability
Accelerometer data will be used to measure sleep midpoint variability in minutes.
Time frame: Before and after the 12 week intervention/intervention period
Objectively measured sedentary behaviour
Accelerometer data will be used to measure total time spent in sedentary time in minutes.
Time frame: Before and after the 12 week intervention/intervention period
Objectively measured physical activity
Accelerometer data will be used to measure total time spent in physical activity in minutes.
Time frame: Before and after the 12 week intervention/intervention period
Subjectively measured sleep - insomnia
The Insomnia Severity index, will be used to measure the level of insomnia - it is a questionnaire and has a range of 0-28 with higher scores indicating more insomnia.
Time frame: Before and after the 12 week intervention/intervention period
Subjectively measured sleep quality -
The Pittsburgh Sleep Quality Index will be used to measure subjective sleep quality, this is a questionnaire and has a range of 0-21 with higher scores indicating worse sleep quality.
Time frame: Before and after the 12 week intervention/intervention period
Subjectively measured sleepiness
Epworth Sleepiness Scale is a questionnaire and has a range of 0-24 with higher scores indicating more sleepiness.
Time frame: Before and after the 12 week intervention/intervention period
Measurement of fatigue
The Functional assessment of chronic illness therapy (FACIT) scale will be used to subjectively measure fatigue, the range is 0-52 with higher scores indicating less fatigue.
Time frame: Before and after the 12 week intervention/intervention period
Blood pressure
Blood pressure (both diastolic and systolic) will be measured using an automatic electronic device and the units used will be millimetres of mercury.
Time frame: Before and after the 12 week intervention/intervention period
Fasting blood glucose
Fasting measured via a venous sample and in millimoles per litre (Mmol/L)
Time frame: Before and after the 12 week intervention/intervention period
Continuous blood glucose
Continuous blood glucose measured via a continuous glucose monitor and in Mmol/L (Mmol/L)
Time frame: Before and after the 12 week intervention/intervention period
Insulin
Insulin will be measured via a venous sample and in micro units per millilitre.
Time frame: Before and after the 12 week intervention/intervention period
Triglycerides
Triglycerides will be measured via a venous sample and in Mmol/L.
Time frame: Before and after the 12 week intervention/intervention period
Cholesterol
Cholesterol, including Low density lipoprotein and high density lipoprotein and total cholesterol, will be measured via a venous sample and in Mmol/L
Time frame: Before and after the 12 week intervention/intervention period
Physical function - the short physical performance battery
The short physical performance battery consists of 3 physical tests, with a total score range of 0-12 with higher scores indicating better physical function.
Time frame: Before and after the 12 week intervention/intervention period
Physical function - the sit to stand-60
The sit to stand-60 is the number of times the participant can rise from sit to stand in one minute using a designated chair with no arms and without the use of the participants arms, and is reported as a number.
Time frame: Before and after the 12 week intervention/intervention period
Physical and Cognitive function - The World Health Organisation Disability Assessment schedule (WHODAS)
WHODAS is a questionnaire used to assess both physical and cognitive function. Each question is scored 0-4, scores are then averaged for all the questions so the range is 0-4 and the higher the score the more difficulty the participant is experiencing in functioning.
Time frame: Before and after the 12 week intervention/intervention period
Cognitive function - verbal fluency test
Cognitive function will be measured using the verbal fluency test, which is conducted over two 60s periods and is scored by the number of correct answers.
Time frame: Before and after the 12 week intervention/intervention period
Quality of life- European Quality of Life 5 dimension (EQ-5D-5L)
EQ-5D-5L, the five questions are scored 1-5 and each represents a different aspect, it is presented as a five digit number representing each domain. The higher the numbers, the worse quality of life.
Time frame: Before and after the 12 week intervention/intervention period
Weight
Weight in kilograms will be measured.
Time frame: Before and after the 12 week intervention/intervention period
Height
Height in metres will be measured.
Time frame: Before and after the 12 week intervention/intervention period
Body mass index (BMI)
BMI will be calculated using weight and height to produce BMI in kg/m\^2
Time frame: Before and after the 12 week intervention/intervention period
Body composition - via bioimpedance
Bioimpedance scales will be used to measure body composition including percentage fat, muscle mass and water
Time frame: Before and after the 12 week intervention/intervention period
Depression - The Patient Health Questionnaire-9 (PHQ9)
PHQ9 will be used to measure depressive symptoms. The PHQ9 has a range of 0-27 with higher scores indicating more depressive symptoms/depression.
Time frame: Before and after the 12 week intervention/intervention period
Anxiety - The General Anxiety Disorder Assessment-7 (GAD7)
GAD7 will be used to measure anxiety symptoms. It has a range of 0-21, with higher scores indicating more anxiety.
Time frame: Before and after the 12 week intervention/intervention period
Food intake - food diaries
3 Day food diaries will be used to measure food intake.
Time frame: Before and after the 12 week intervention/intervention period
Plan to share: Undecided — Data in anonymised form may be suitable for sharing at the end of the trial. Should there be concerns about protecting the identity of participants/commercialisation of outputs, access restrictions will need to be considered. If suitable, anonymised data may be added to UoL's Research Archive (https://figshare.le.ac.uk/) within 6 months of the trial end date. The repository is registered in OpenDOAR and preserves research outputs (minimum of 10 years).
No publications or documents are linked to this record.
Started Sep 2024 (actual). Primary completion is estimated for Jul 2026, 22 months after the start.
Of 2,078 non-industry interventional studies with no phase under Diabetes Mellitus, Type 2, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 40. This study's planned 22 months is close to that.
Counting every sponsor, half of 2,255 studies reached it within 21 months; a quarter within 10 and three quarters within 39.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.